ScholarIQanswers from OpenAlex & ORCID
Jeffrey M. Fowler
ResearcherPublications, citations & collaboration network
Jeffrey M. Fowler is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jeffrey M. Fowler have?
ScholarIQindexed works
Jeffrey M. Fowler has 281 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jeffrey M. Fowler have?
ScholarIQcitation count
Jeffrey M. Fowler has 16,759 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jeffrey M. Fowler?
ScholarIQh-index
Jeffrey M. Fowler has an h-index of 59 in OpenAlex.
What is the i10-index of Jeffrey M. Fowler?
ScholarIQi10-index
Jeffrey M. Fowler has an i10-index of 151 in OpenAlex.
What is the OpenAlex record for Jeffrey M. Fowler?
ScholarIQopenalex
The OpenAlex for Jeffrey M. Fowler is on the source record.
What are the most-cited papers on Jeffrey M. Fowler?
ScholarIQmost cited works
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke‐Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca N. Baergen
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
Michael A. Bookman, Mark F. Brady, William P. McGuire, Peter Harper, David S. Alberts, Michael Friedländer, Nicoletta Colombo, Jeffrey M. Fowler, Peter A. Argenta, Koen De Geest, David G. Mutch, Robert A. Burger, Ann Marie Swart, Edward L. Trimble, Chrisann Accario-Winslow, Lawrence M. Roth
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro, Barbara M. Norquist, Elizabeth M. Swisher, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Helen Huang, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Sharon X. Liang, Chenglin Ye, Carlos Bais, Leslie M. Randall, John K. Chan, J. Stuart Ferriss, Robert L. Coleman, Carol Aghajanian, Thomas J. Herzog, Philip J. DiSaia, Larry J. Copeland, Robert S. Mannel, Michael J. Birrer, Bradley J. Monk